TIBET PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 269 million yuan, a year-on-year decrease of 13.95%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, TIBET PHARMA disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 712 million yuan, a year-on-year increase of 1.12%; the net profit attributable to the parent company was 269 million yuan, a year-on-year decrease of 13.95%; the net profit excluding non-recurring gains and losses was 253 million yuan, a year-on-year increase of 7.90%. The basic earnings per share were 0.84 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments